Log In
Print
BCIQ
Print
Print this Print this
 

foralumab (NI-0401)

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb targeting CD3e
Molecular Target CD3e molecule epsilon CD3-TCR complex (CD3E)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today